Stock Analysis

Industry Analysts Just Made A Huge Upgrade To Their Mabion S.A. (WSE:MAB) Revenue Forecasts

WSE:MAB
Source: Shutterstock

Mabion S.A. (WSE:MAB) shareholders will have a reason to smile today, with the analysts making substantial upgrades to this year's forecasts. The analysts have sharply increased their revenue numbers, with a view that Mabion will make substantially more sales than they'd previously expected.

After this upgrade, Mabion's dual analysts are now forecasting revenues of zł173m in 2023. This would be a modest 5.2% improvement in sales compared to the last 12 months. Before the latest update, the analysts were foreseeing zł123m of revenue in 2023. The consensus has definitely become more optimistic, showing a great increase in revenue forecasts.

See our latest analysis for Mabion

earnings-and-revenue-growth
WSE:MAB Earnings and Revenue Growth June 2nd 2023

Looking at the bigger picture now, one of the ways we can make sense of these forecasts is to see how they measure up against both past performance and industry growth estimates. It's pretty clear that there is an expectation that Mabion's revenue growth will slow down substantially, with revenues to the end of 2023 expected to display 7.0% growth on an annualised basis. This is compared to a historical growth rate of 94% over the past five years. Compare this against other companies (with analyst forecasts) in the industry, which are in aggregate expected to see revenue growth of 22% annually. So it's pretty clear that, while revenue growth is expected to slow down, the wider industry is also expected to grow faster than Mabion.

The Bottom Line

The highlight for us was that analysts increased their revenue forecasts for Mabion this year. They also expect company revenue to perform worse than the wider market. Given that analysts appear to be expecting substantial improvement in the sales pipeline, now could be the right time to take another look at Mabion.

Hungry for more information? At least one of Mabion's dual analysts has provided estimates out to 2025, which can be seen for free on our platform here.

Of course, seeing company management invest large sums of money in a stock can be just as useful as knowing whether analysts are upgrading their estimates. So you may also wish to search this free list of stocks that insiders are buying.

Valuation is complex, but we're helping make it simple.

Find out whether Mabion is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.